Effects of Prior Cushing’s Syndrome

Jun 27, 2017 by in ENDOCRINOLOGY Comments Off on Effects of Prior Cushing’s Syndrome

Fig. 1 Main clinical manifestations after remission of Cushing’s syndrome This chapter addresses current information on the main long-term/persistent effects of prior Cushing’s disease/glucocorticoid exposure. Cardiovascular and Metabolic Comorbidities Hypercortisolism…

read more

Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor

Jun 27, 2017 by in ENDOCRINOLOGY Comments Off on Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor

Target tissue Glucocorticoid hypersensitivity = Glucocorticoid excess Glucocorticoid resistance = Glucocorticoid deficiency Central nervous system Insomnia, anxiety, depression, defective cognition Fatigue, somnolence, malaise, defective cognition Liver + Gluconeogenesis, + lipogenesis…

read more

and Nonneoplastic/Physiological Hypercortisolism: Cushing Versus Pseudo-Cushing Syndromes

Jun 27, 2017 by in ENDOCRINOLOGY Comments Off on and Nonneoplastic/Physiological Hypercortisolism: Cushing Versus Pseudo-Cushing Syndromes

Neoplastic/pathological hypercortisolism ACTH-secreting neoplasm  Pituitary (Cushing disease)  Non-pituitary (ectopic ACTH) Adrenal neoplastic disease  Adrenocortical adenoma  Adrenocortical carcinoma  Bilateral adrenal nodular disease   Primary pigmented micronodular hyperplasia   Primary bilateral macronodular hyperplasia Nonneoplastic/physiological…

read more

Adrenal Cortisol Excess

Jun 27, 2017 by in ENDOCRINOLOGY Comments Off on Adrenal Cortisol Excess

Fig. 1 Left adrenal incidentaloma with subtle autonomous cortisol secretion in a 37-year-old woman (white arrow); the right adrenal gland is partially atrophied (black arrow). Over 1 year, the cortisol…

read more

Therapies in Cushing’s Syndrome

Jun 27, 2017 by in ENDOCRINOLOGY Comments Off on Therapies in Cushing’s Syndrome

Steroidogenesis inhibitors Ketoconazole Metyrapone Mitotane Etomidate Centrally acting agents Cabergoline Pasireotide Glucocorticoid receptor antagonist Mifepristone Note: With the exception of pasireotide and mifepristone, these agents are used “off-label” in Cushing’s…

read more
Get Clinical Tree app for offline access